Assembly Biosciences (ASMB) Net Income towards Common Stockholders Growth (5y) (2015 - 2026)
Assembly Biosciences (ASMB) Net Income towards Common Stockholders Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Assembly Biosciences | 431.63 Mn | 205.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.37% |
| Dec 31, 2025 | 20.69% |
| Sep 30, 2025 | -22.39% |
| Jun 30, 2025 | -27.75% |
| Mar 31, 2025 | 17.83% |
| Dec 31, 2024 | 17.53% |
| Sep 30, 2024 | 17.40% |
| Jun 30, 2024 | 9.63% |
| Mar 31, 2024 | 19.62% |
| Dec 31, 2023 | 15.24% |
| Sep 30, 2023 | 7.71% |
| Jun 30, 2023 | 8.82% |
| Mar 31, 2023 | -3.47% |
| Dec 31, 2022 | -14.91% |
| Sep 30, 2022 | -13.78% |
| Jun 30, 2022 | -12.68% |
| Mar 31, 2022 | 24.66% |
| Dec 31, 2021 | -40.72% |
| Sep 30, 2021 | -18.43% |
| Jun 30, 2021 | -19.38% |